What procurement model suits mid-sized biotechs entering the Drug Discovery Informatics Market?

Tiered cloud subscriptions with per-seat pricing avoid upfront capital. Start with registration and electronic notebook modules, then layer predictive tools once assay workflows stabilize and data quality is proven. [Ref 12] Read More

How long does an enterprise platform implementation typically take?

Six to fourteen months, with legacy data migration — not software configuration — driving the timeline. Phased rollouts by therapeutic area deliver measurable value faster than big-bang deployments. [Ref 13] Read More

Which contract terms matter most when buying into the Drug Discovery Informatics Market?

Data portability and bulk export rights rank first. Negotiate model-ownership clauses covering any algorithm trained on your proprietary compound libraries before signing. [Ref 9] Read More

Do open-source toolkits displace commercial vendors?

Rarely at enterprise scale. Open-source components handle discrete computational tasks well, but regulated environments require audit trails, validation packages, and vendor indemnification that community projects do not supply. [Ref 16] Read More

What integration risk most often derails Drug Discovery Informatics Market deployments?

Instrument connectivity. Legacy screening and chromatography hardware frequently lacks modern APIs, forcing custom middleware that inflates project budgets by 15–25%. [Ref 13] Read More

How should buyers evaluate AI model quality during vendor selection?

Request prospective validation on blinded internal datasets rather than published benchmarks. Retrospective accuracy on public data rarely predicts performance within a sponsor's proprietary chemical space. [Ref 3] Read More

Are discounted licences realistically available to early-stage startups?

Yes, through incubator and accelerator partnerships. Several vendors offer reduced tiers below a revenue threshold, converting to commercial rates around Series B financing. [Ref 20] Read More

Drug Discovery Informatics Market

ID: MRFR/HC/6360-HCR 90 Pages Vikita Thakur Last Updated: October 06, 2026

Drug Discovery Informatics Market Research Report: Size, Share, Trend Analysis By Product (Discovery Informatics, Development Informatics), Mode (In-House Informatics and Outsourced Informatics), Service (Sequencing and Target Data Analysis, Docking, Molecular Modeling, Clinical Trial Data Management and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Healthcare Informatics Industry Forecast Till 2035

Drug Discovery Informatics Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.4%

2024 Market Size$ 3.8 Billion

2025 Market Size$ 3.15 Billion

2035 Market Size$ 10.21 Billion

Key Players

Companies such as Thermo Fisher Scientific

PerkinElmer

Schrodinger

Cresset

Certara

Bioinformatics Solutions

Trends

AI-Driven Target Identification and Lead Optimization
R&D Spend Concentration and Productivity Pressure
Multi-Omics Data Expansion

Opportunities

Federated Learning Across Sponsor Consortia
Emerging-Market Discovery Hubs
Data Monetization and Outcome-Linked Licensing

Summary Table of Contents Segmentation Download PDF

1 Market Summary |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Key Report Takeaways |
1. 2.1 By Technology / Function |
2. 2.2 By Sector / End User |
3. 2.3 By Geography
3 Market Size & Forecast (2021–2035) |
1. 3.1 Historical Market Size (2021–2024) |
2. 3.2 Base Year Calibration (2025) |
3. 3.3 Forecast Market Size (2026–2035) |
4. 3.4 Year-over-Year Growth Analysis
4 Driver Impact Analysis |
1. 4.1 AI-Driven Target Identification and Lead Optimization |
2. 4.2 R&D Spend Concentration and Productivity Pressure |
3. 4.3 Multi-Omics Data Expansion |
4. 4.4 Regulatory Clarity on Computational Evidence
5 Restraints Impact Analysis |
1. 5.1 Data Fragmentation and FAIR Deficits |
2. 5.2 Total Cost of Ownership for Mid-Sized Buyers |
3. 5.3 Talent Scarcity
6 Opportunity Analysis |
1. 6.1 Federated Learning Across Sponsor Consortia |
2. 6.2 Emerging-Market Discovery Hubs |
3. 6.3 Data Monetization and Outcome-Linked Licensing |
4. 6.4 Biologics and New-Modality Informatics |
5. 6.5 Regulatory Submission Automation |
6. 6.6 Industry Value Chain Analysis |
7. 6.7 Porter's Five Forces Analysis
7 Regional Market Share & Country-Level Analysis |
1. 7.1 North America | |
  1. 7.1.1 US | |
  2. 7.1.2 Canada | |
  3. 7.1.3 Mexico |
2. 7.2 Europe | |
  1. 7.2.1 Germany | |
  2. 7.2.2 UK | |
  3. 7.2.3 France | |
  4. 7.2.4 Italy | |
  5. 7.2.5 Spain | |
  6. 7.2.6 Nordic Countries | |
  7. 7.2.7 Russia | |
  8. 7.2.8 Rest of Europe |
3. 7.3 Asia-Pacific | |
  1. 7.3.1 China | |
  2. 7.3.2 India | |
  3. 7.3.3 Japan | |
  4. 7.3.4 South Korea | |
  5. 7.3.5 ASEAN | |
  6. 7.3.6 Rest of Asia-Pacific |
4. 7.4 South America | |
  1. 7.4.1 Brazil | |
  2. 7.4.2 Argentina | |
  3. 7.4.3 Rest of South America |
5. 7.5 Middle East & Africa | |
  1. 7.5.1 Saudi Arabia | |
  2. 7.5.2 UAE | |
  3. 7.5.3 South Africa | |
  4. 7.5.4 Egypt | |
  5. 7.5.5 Rest of Middle East & Africa
8 Future Outlook (2026–2035) |
1. 8.1 Autonomous Experimentation Loops |
2. 8.2 Platform Economics and Consolidation |
3. 8.3 Foundation Models for Biology |
4. 8.4 Validation as a Product Category
9 Market Segmentation Analysis |
1. 9.1 By Function | |
  1. 9.1.1 Sequencing & Target Data Analysis | |
  2. 9.1.2 Molecular Modeling | |
  3. 9.1.3 Docking | |
  4. 9.1.4 Libraries & Database Preparation | |
  5. 9.1.5 Other Functions |
2. 9.2 By Solution | |
  1. 9.2.1 Software | |
  2. 9.2.2 Services |
3. 9.3 By Workflow | |
  1. 9.3.1 Discovery Informatics | |
  2. 9.3.2 Development Informatics |
4. 9.4 By End User | |
  1. 9.4.1 Pharmaceutical Companies | |
  2. 9.4.2 Biotechnology Companies | |
  3. 9.4.3 Contract Research Organizations | |
  4. 9.4.4 Academic & Research Institutes
10 Competitive Landscape |
1. 10.1 Market Concentration Analysis (2026) |
2. 10.2 Competitive Benchmarking Matrix |
3. 10.3 Company Profiles | |
  1. 10.3.1 Dassault Systèmes (BIOVIA) | |
  2. 10.3.2 Dotmatics (Siemens) | |
  3. 10.3.3 Certara | |
  4. 10.3.4 Schrödinger | |
  5. 10.3.5 Thermo Fisher Scientific | |
  6. 10.3.6 Revvity Signals Software | |
  7. 10.3.7 Charles River Laboratories | |
  8. 10.3.8 Benchling | |
  9. 10.3.9 Chemical Computing Group | |
  10. 10.3.10 Simulations Plus | |
  11. 10.3.11 Genedata | |
  12. 10.3.12 Collaborative Drug Discovery
11 Recent News & Developments
12 Report Scope & Methodology |
1. 12.1 Study Period & Base Year |
2. 12.2 Data Sources & Triangulation |
3. 12.3 Abbreviations
13 Detailed Sources & Citations
14 Frequently Asked Questions
15 LIST OF TABLES |
TABLE 1 Global Drug Discovery Informatics Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Drug Discovery Informatics Market – Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Driver Impact Analysis Matrix, 2026–2035 |
TABLE 4 Restraint Impact Analysis Matrix, 2026–2035 |
TABLE 5 Global Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 6 North America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 7 Europe Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 8 Asia-Pacific Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 9 South America Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Middle East & Africa Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Global Market Size, by Function, 2021–2035 (USD Billion) |
TABLE 12 Global Market Size, by Solution, 2021–2035 (USD Billion) |
TABLE 13 Global Market Size, by Workflow, 2021–2035 (USD Billion) |
TABLE 14 Global Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 15 North America Market Size, by Function, 2021–2035 (USD Billion) |
TABLE 16 North America Market Size, by Solution, 2021–2035 (USD Billion) |
TABLE 17 North America Market Size, by Workflow, 2021–2035 (USD Billion) |
TABLE 18 North America Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 19 Europe Market Size, by Function, 2021–2035 (USD Billion) |
TABLE 20 Europe Market Size, by Solution, 2021–2035 (USD Billion) |
TABLE 21 Europe Market Size, by Workflow, 2021–2035 (USD Billion) |
TABLE 22 Europe Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 23 Asia-Pacific Market Size, by Function, 2021–2035 (USD Billion) |
TABLE 24 Asia-Pacific Market Size, by Solution, 2021–2035 (USD Billion) |
TABLE 25 Asia-Pacific Market Size, by Workflow, 2021–2035 (USD Billion) |
TABLE 26 Asia-Pacific Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 27 South America Market Size, by Function, 2021–2035 (USD Billion) |
TABLE 28 South America Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 29 Middle East & Africa Market Size, by Function, 2021–2035 (USD Billion) |
TABLE 30 Middle East & Africa Market Size, by End User, 2021–2035 (USD Billion) |
TABLE 31 US Market Size, by Function and Solution, 2021–2035 (USD Billion) |
TABLE 32 Germany Market Size, by Function and Solution, 2021–2035 (USD Billion) |
TABLE 33 China Market Size, by Function and Solution, 2021–2035 (USD Billion) |
TABLE 34 India Market Size, by Function and Solution, 2021–2035 (USD Billion) |
TABLE 35 Japan Market Size, by Function and Solution, 2021–2035 (USD Billion) |
TABLE 36 Competitive Benchmarking Matrix, 2026 |
TABLE 37 Company Profiles – Key Players |
TABLE 38 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 39 Report Scope & Methodology Summary |
TABLE 40 Detailed Sources & Citations Index
16 LIST OF FIGURES |
FIGURE 1 Market Dynamics – Drivers, Restraints, and Opportunities Snapshot |
FIGURE 2 Industry Value Chain Analysis |
FIGURE 3 Porter's Five Forces Assessment |
FIGURE 4 Global Market Size Trend, 2021–2035 (USD Billion) |
FIGURE 5 Year-over-Year Growth Trajectory, 2022–2035 (%) |
FIGURE 6 Market Share by Function, 2025 vs 2035 (%) |
FIGURE 7 Market Share by Solution, 2025 vs 2035 (%) |
FIGURE 8 Market Share by Workflow, 2025 vs 2035 (%) |
FIGURE 9 Market Share by End User, 2025 vs 2035 (%) |
FIGURE 10 Regional Revenue Share, 2025 (%) |
FIGURE 11 Regional CAGR Comparison, 2026–2035 (%) |
FIGURE 12 North America Country-Level Share, 2025 (%) |
FIGURE 13 Europe Country-Level Share, 2025 (%) |
FIGURE 14 Asia-Pacific Country-Level Share, 2025 (%) |
FIGURE 15 Competitive Positioning Quadrant, 2026 |
FIGURE 16 Estimated Vendor Revenue Share Distribution, 2026 |
FIGURE 17 M&A and Partnership Activity Timeline, 2023–2025 |
FIGURE 18 Technology Adoption Curve – Discovery Informatics Capabilities

Certified Researchers

Enquiry

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Function	Sequencing & Target Data Analysis; Molecular Modeling; Docking; Libraries & Database Preparation; Other Functions	Sequencing & Target Data Analysis	Molecular Modeling
By Solution	Software; Services	Software	Services
By Workflow	Discovery Informatics; Development Informatics	Discovery Informatics	Development Informatics
By End User	Pharmaceutical Companies; Biotechnology Companies; Contract Research Organizations; Academic & Research Institutes	Pharmaceutical Companies	Contract Research Organizations
By Geography	North America; Europe; Asia-Pacific; South America; Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

Segment structures below mirror the analytical taxonomy applied throughout the Drug Discovery Informatics Market report.

By Function

Sub-Segment	Key Trend
Sequencing & Target Data Analysis	Biobank linkage and single-cell datasets drive harmonization spend
Molecular Modeling	GPU-affordable free-energy methods enter routine medicinal chemistry
Docking	Ultra-large virtual libraries shift screening economics toward compute
Libraries & Database Preparation	Registration systems become the enterprise system of record
Other Functions	Predictive ADMET and toxicology gain regulatory acceptance

Function-level demand tracks where uncertainty is most expensive. Buyers fund analysis closest to target validation first, because errors there propagate through every downstream decision and cost the most to reverse.

By Solution

Sub-Segment	Key Trend
Software	Subscription conversion and modular tiering broaden the addressable buyer base
Services	Data remediation and model tuning attach to nearly every enterprise contract

Solution mix is rebalancing steadily. Talent scarcity means sponsors increasingly rent expertise from vendors rather than hire, lifting services growth above licence growth across the forecast decade.

By Workflow

Sub-Segment	Key Trend
Discovery Informatics	Target-to-lead cycle compression remains the primary purchase justification
Development Informatics	Unbroken data lineage from assay to submission becomes an RFP requirement

Workflow boundaries are eroding. Sponsors that once bought discovery and development tooling separately now demand a single provenance chain, favouring vendors with credible coverage on both sides of the candidate-nomination gate.

By End User

Sub-Segment	Key Trend
Pharmaceutical Companies	Multi-year enterprise agreements with low churn and expanding module counts
Biotechnology Companies	Cloud-first architecture adopted from company formation onward
Contract Research Organizations	Data deliverables written into statements of work force platform investment
Academic & Research Institutes	Public translational funding subsidizes industrial-grade tooling access

End-user growth differentials reflect contracting practice more than technology preference. Where sponsors specify data format and lineage in the contract, service providers must match their client's stack — and that requirement is now standard in competitive bids.

Certified Researchers

Enquiry

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”